Cancer center recognized nationally for excellence in surgical oncology care
UC Davis Comprehensive Cancer Center has been designated an American College of Surgeons (ACS) Surgical Quality Partner. The award is given to cancer programs that excel at providing quality of care, preventing complications, saving lives, and reducing costs.
ACS quality programs are grounded in more than a century of experience and are an important measure of a hospital’s surgical quality.
The designation follows the news that UC Davis Medical Center and UC Davis Comprehensive Cancer Center earned accreditation once again from the Commission on Cancer (CoC), a quality program of the ACS.
To achieve renewal of its CoC accreditation, a site visit was conducted in August to confirm compliance with accreditation standards that evaluate cancer care services. The cancer center received a three-year re-accreditation without any non-compliant standards.
“This is the first year where the ACS Commission on Cancer acknowledged programs that exemplify our commitment to quality by presenting us with the Surgical Quality Partner diamond recognition as part of our re-accreditation,” UC Davis Comprehensive Cancer Center Physician- in-Chief Richard Bold said. “This designation means that our commitment to maintaining the highest standards in surgical care shows and is making a difference.
In its notification to the cancer center, the ACS CoC said, “We created the Surgical Quality Partner designation to assist our partner hospitals in highlighting their participation in our quality programs to their patients and communities. We know that this designation will be important to your patients and will distinguish your hospital.”
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. For more information, visit cancer.ucdavis.edu.